Life Sciences

Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.

Teladoc says the acquisition will help the company better serve a broader population of people who need virtual mental health care.  

Americans with a prescription will have access to Novo Nordisk's obesity drug Wegovy through the Hims & Hers platform for $599 monthly.

The partnership will merge Commure’s EHR integrations, AI-powered tools and care coordination with HealthTap’s clinician network and virtual care delivery offerings.  

Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.

The collaboration will increase the use cases for healthcare professionals to create care protocols and new treatments in oncology and promote precision medicine.

Juan Lavista Ferres, CVP and chief data scientist at Microsoft's AI for Good Lab, and Meghana Kshirsagar, senior research scientist, discuss their research on protein symmetry.

Equiva will integrate Belong.Life's offerings into its digital platform to give patients and caregivers access to AI health mentors.   

Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.

The alliance will combine HeartBeam's ECG device with AccurKardia's monitoring software.